$BLPG
Blue Line Protection Group, Inc.

2023 Q3 Form 10-Q Financial Statement

#000149315223028115 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $1.106M $1.105M
YoY Change 21.21% 12.15%
Cost Of Revenue $388.9K $367.7K
YoY Change 12.55% 18.37%
Gross Profit $717.1K $736.8K
YoY Change 26.48% 9.29%
Gross Profit Margin 64.84% 66.71%
Selling, General & Admin $500.0K $559.9K
YoY Change -18.25% 3.28%
% of Gross Profit 69.73% 75.98%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $26.96K $33.48K
YoY Change -30.46% 0.89%
% of Gross Profit 3.76% 4.54%
Operating Expenses $495.9K $559.9K
YoY Change -18.92% 3.28%
Operating Profit $221.2K $177.0K
YoY Change -595.41% 33.94%
Interest Expense $44.93K $55.44K
YoY Change 301.24% -26.05%
% of Operating Profit 20.31% 31.32%
Other Income/Expense, Net -$15.53K -$46.08K
YoY Change -71.91% -185.64%
Pretax Income $210.0K $130.9K
YoY Change -310.15% -29.59%
Income Tax
% Of Pretax Income
Net Earnings $205.6K $130.9K
YoY Change -305.79% -29.6%
Net Earnings / Revenue 18.59% 11.85%
Basic Earnings Per Share $0.02 $0.02
Diluted Earnings Per Share $0.02 $0.02
COMMON SHARES
Basic Shares Outstanding 8.250M shares 8.250M shares
Diluted Shares Outstanding 17.47M shares 13.04M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $510.0K $413.1K
YoY Change 36.27% -29.36%
Cash & Equivalents $514.7K $413.1K
Short-Term Investments
Other Short-Term Assets $30.00K $33.60K
YoY Change -3.88% 7.66%
Inventory
Prepaid Expenses
Receivables $362.2K $386.1K
Other Receivables $0.00 $0.00
Total Short-Term Assets $910.5K $832.7K
YoY Change 33.37% -8.83%
LONG-TERM ASSETS
Property, Plant & Equipment $887.1K $843.6K
YoY Change 18.05% 3.47%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $30.00K $34.70K
YoY Change -13.54% -5.55%
Total Long-Term Assets $919.1K $875.5K
YoY Change 22.29% 7.39%
TOTAL ASSETS
Total Short-Term Assets $910.5K $832.7K
Total Long-Term Assets $919.1K $875.5K
Total Assets $1.830M $1.708M
YoY Change 27.57% -1.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $660.0K $564.0K
YoY Change 17.26% -29.62%
Accrued Expenses $160.0K $91.18K
YoY Change 31.68% -30.14%
Deferred Revenue
YoY Change
Short-Term Debt $690.0K $714.5K
YoY Change -11.28% -23.07%
Long-Term Debt Due $20.00K $22.55K
YoY Change -64.23% -59.67%
Total Short-Term Liabilities $1.930M $1.845M
YoY Change -4.32% -27.84%
LONG-TERM LIABILITIES
Long-Term Debt $850.0K $914.6K
YoY Change -21.55% -20.54%
Other Long-Term Liabilities $490.0K $592.8K
YoY Change 39.11% 58.08%
Total Long-Term Liabilities $1.346M $1.507M
YoY Change -6.28% -1.21%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.930M $1.845M
Total Long-Term Liabilities $1.346M $1.507M
Total Liabilities $3.276M $3.352M
YoY Change -5.13% -17.89%
SHAREHOLDERS EQUITY
Retained Earnings -$11.63M -$11.84M
YoY Change -0.86% 1.76%
Common Stock $8.251K $8.251K
YoY Change 0.3% -2.77%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.446M -$1.644M
YoY Change
Total Liabilities & Shareholders Equity $1.830M $1.708M
YoY Change 27.57% -1.19%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $205.6K $130.9K
YoY Change -305.79% -29.6%
Depreciation, Depletion And Amortization $26.96K $33.48K
YoY Change -30.46% 0.89%
Cash From Operating Activities $290.0K $89.36K
YoY Change 1745.96% -13.93%
INVESTING ACTIVITIES
Capital Expenditures $100.0K $0.00
YoY Change -1388.66% -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$100.0K $0.00
YoY Change 1188.66% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -80.00K -85.62K
YoY Change -63.37% -14.17%
NET CHANGE
Cash From Operating Activities 290.0K 89.36K
Cash From Investing Activities -100.0K 0.000
Cash From Financing Activities -80.00K -85.62K
Net Change In Cash 110.0K 3.740K
YoY Change -152.27% -153.05%
FREE CASH FLOW
Cash From Operating Activities $290.0K $89.36K
Capital Expenditures $100.0K $0.00
Free Cash Flow $190.0K $89.36K
YoY Change 709.54% -22.26%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001416697
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
BLPG Stock Option Expense
StockOptionExpense
usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
BLPG Capitalized Leased Fixed Assets
CapitalizedLeasedFixedAssets
usd
BLPG Initial Recognition Of Right To Use Asset And Lease Liability
InitialRecognitionOfRightToUseAssetAndLeaseLiability
usd
CY2022Q2 us-gaap Depreciation
Depreciation
33186 usd
CY2023Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
usd
CY2022Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
usd
CY2023Q2 us-gaap Advertising Expense
AdvertisingExpense
685 usd
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4970362 shares
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
497036216 shares
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
usd
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-52942
dei Entity Registrant Name
EntityRegistrantName
BLUE LINE PROTECTION GROUP, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-5543728
dei Entity Address Address Line1
EntityAddressAddressLine1
5765 Logan St.
dei Entity Address City Or Town
EntityAddressCityOrTown
Denver
dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80216
dei City Area Code
CityAreaCode
(800)
dei Local Phone Number
LocalPhoneNumber
844-5576
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8250144 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
413080 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
280073 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
386066 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
373175 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
33601 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
31553 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
832747 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
684801 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
654966 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
408616 usd
CY2023Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
185815 usd
CY2022Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
254227 usd
CY2023Q2 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment
2782 usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment
2782 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
843563 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
665625 usd
CY2023Q2 us-gaap Security Deposit
SecurityDeposit
31920 usd
CY2022Q4 us-gaap Security Deposit
SecurityDeposit
31920 usd
CY2023Q2 us-gaap Assets
Assets
1708230 usd
CY2022Q4 us-gaap Assets
Assets
1382346 usd
CY2023Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
564012 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
555445 usd
CY2023Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
22549 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
31719 usd
CY2023Q2 BLPG Convertible Notes Payable Related Parties Current Net Of Unamortized Discount
ConvertibleNotesPayableRelatedPartiesCurrentNetOfUnamortizedDiscount
561730 usd
CY2022Q4 BLPG Convertible Notes Payable Related Parties Current Net Of Unamortized Discount
ConvertibleNotesPayableRelatedPartiesCurrentNetOfUnamortizedDiscount
604256 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
91175 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
112250 usd
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
452744 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
451119 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1844981 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1907560 usd
CY2023Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
25903 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
37568 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
592827 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
328116 usd
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1507387 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1366184 usd
CY2023Q2 us-gaap Liabilities
Liabilities
3352368 usd
CY2022Q4 us-gaap Liabilities
Liabilities
3273744 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
20000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
20000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
20000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
20000000 shares
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
20000 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
20000 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
14000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
14000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8250144 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8250144 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8250144 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8250144 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
8251 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
8251 usd
CY2023Q2 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
129 shares
CY2022Q4 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
129 shares
CY2023Q2 BLPG Common Stock Owed But Not Issued
CommonStockOwedButNotIssued
13 usd
CY2022Q4 BLPG Common Stock Owed But Not Issued
CommonStockOwedButNotIssued
13 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10168006 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10046096 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11840408 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11965758 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1644138 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1891398 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1708230 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1382346 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1104501 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
984811 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2113567 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1985067 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
367652 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
310592 usd
us-gaap Cost Of Revenue
CostOfRevenue
728579 usd
us-gaap Cost Of Revenue
CostOfRevenue
593697 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
736849 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
674219 usd
us-gaap Gross Profit
GrossProfit
1384988 usd
us-gaap Gross Profit
GrossProfit
1391370 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
559853 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
542075 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1111985 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1055616 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
559853 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
542075 usd
us-gaap Operating Expenses
OperatingExpenses
1111985 usd
us-gaap Operating Expenses
OperatingExpenses
1055616 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
176996 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
132144 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
273003 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
335754 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
55437 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
74970 usd
us-gaap Interest Expense
InterestExpense
98934 usd
us-gaap Interest Expense
InterestExpense
140738 usd
CY2023Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
9356 usd
CY2022Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
128777 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-48719 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-159276 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-46081 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
53807 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-147653 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-300014 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
130915 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
185951 usd
us-gaap Net Income Loss
NetIncomeLoss
125350 usd
us-gaap Net Income Loss
NetIncomeLoss
35740 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8250144 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8485144 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8398062 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8485144 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13040506 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16525144 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13188424 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16525144 shares
us-gaap Net Income Loss
NetIncomeLoss
125350 usd
us-gaap Net Income Loss
NetIncomeLoss
35740 usd
us-gaap Depreciation
Depreciation
68412 usd
us-gaap Depreciation
Depreciation
57267 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
66082 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
58685 usd
BLPG Stock Option Expense
StockOptionExpense
74816 usd
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
48719 usd
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
159276 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12891 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-30534 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2048 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1830 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
8567 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
63201 usd
BLPG Increase Decrease In Lease Obligation
IncreaseDecreaseInLeaseObligation
68796 usd
BLPG Increase Decrease In Lease Obligation
IncreaseDecreaseInLeaseObligation
60111 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
308211 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
342762 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11122 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11122 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
42526 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
187500 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
111843 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
204240 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
20835 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
17344 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-175204 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-409084 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
133007 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-77444 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
280073 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
662177 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
413080 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
584733 usd
us-gaap Interest Paid Net
InterestPaidNet
40305 usd
us-gaap Interest Paid Net
InterestPaidNet
24230 usd
BLPG Capitalized Leased Fixed Assets
CapitalizedLeasedFixedAssets
68872 usd
BLPG Derivative Resolution
DerivativeResolution
47094 usd
BLPG Derivative Resolution
DerivativeResolution
231812 usd
BLPG Initial Recognition Of Right To Use Asset And Lease Liability
InitialRecognitionOfRightToUseAssetAndLeaseLiability
312432 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-2582551 usd
CY2022Q2 BLPG Adjustments To Additional Paid In Capital Derivative Resolution
AdjustmentsToAdditionalPaidInCapitalDerivativeResolution
42547 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
185951 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-2354053 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1837378 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
39306 usd
CY2023Q2 BLPG Adjustments To Additional Paid In Capital Derivative Resolution
AdjustmentsToAdditionalPaidInCapitalDerivativeResolution
23019 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
130915 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1644138 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-2621605 usd
BLPG Adjustments To Additional Paid In Capital Derivative Resolution
AdjustmentsToAdditionalPaidInCapitalDerivativeResolution
231812 usd
us-gaap Net Income Loss
NetIncomeLoss
35740 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-2354053 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1891398 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
74816 usd
BLPG Adjustments To Additional Paid In Capital Derivative Resolution
AdjustmentsToAdditionalPaidInCapitalDerivativeResolution
47094 usd
us-gaap Net Income Loss
NetIncomeLoss
125350 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1644138 usd
CY2006Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2006Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q2 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
On May 6, 2014, the Company effected a forward stock split and a pro-rata increase in its authorized common stock on a basis of 14-to-1, whereby each shareholder received 14 newly issued shares of common stock for each 1 share held.
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1400000000 shares
CY2021Q3 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-100
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
14000000 shares
us-gaap Depreciation
Depreciation
68412 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84A_eus-gaap--UseOfEstimates_zsQZ5rok5YLd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zyT2qcL0WBW2">Use of estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Depreciation
Depreciation
57267 usd
CY2022 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
6673 usd
CY2023Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
163080 usd
CY2023Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
us-gaap Financing Receivable Allowance For Credit Losses Policy For Uncollectible Amounts
FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts
<p id="xdx_845_eus-gaap--FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts_zvqoMnyf9Tq9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_z8hexx3wxj65">Allowance for uncollectible accounts</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company estimates losses on receivables based on known troubled accounts, if any, and historical experience of losses incurred. There was <span id="xdx_906_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_do_c20230630_zqy8OLBGTAe8" title="Allowance for doubtful receivables"><span id="xdx_907_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_do_c20221231_z2coRZMqKOLg" title="Allowance for doubtful receivables">no</span></span> allowance for doubtful customer receivables at June 30, 2023 and December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2023Q2 us-gaap Depreciation
Depreciation
33483 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_zzbNYPce4xJ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zB6Q3doM4Jd8">Concentration of business and credit risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has no significant off-balance sheet risks such as foreign exchange contracts, option contracts or other hedging arrangements. The Company’s financial instruments that are exposed to concentration of credit risks consist primarily of cash. The Company maintains its cash in bank accounts, which may at times, exceed federally insured limits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had one major customer which generated <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230630__srt--MajorCustomersAxis__custom--OneMajorCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z8XYufLFG1xd" title="Concentration credit risk, percentage">9.7</span>% of total revenue for the six months ended June 30, 2023 and one customer comprised <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230630__srt--MajorCustomersAxis__custom--OneMajorCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zMxORGTIpKV8" title="Concentration credit risk, percentage">22.9</span>% of the account receivable balance at June 30, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had one major customer which generated <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220630__srt--MajorCustomersAxis__custom--OneMajorCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zTVdUiZKNdd4" title="Concentration credit risk, percentage">26</span>% of total revenue for the six months ended June 30, 2022 and one customer comprised <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220630__srt--MajorCustomersAxis__custom--OneMajorCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z60bzuu2iQgd" title="Concentration credit risk, percentage">33</span>% of the account receivable balance at June 30, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
452744 usd
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
452744 usd
CY2022Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
451119 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
451119 usd
CY2023Q2 us-gaap Revenues
Revenues
1104501 usd
CY2022Q2 us-gaap Revenues
Revenues
984811 usd
us-gaap Revenues
Revenues
2113567 usd
us-gaap Revenues
Revenues
1985067 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
648002 usd
CY2022Q4 BLPG Operating Right Of Use Assets Lease
OperatingRightOfUseAssetsLease
408616 usd
us-gaap Advertising Expense
AdvertisingExpense
4704 usd
CY2022Q2 us-gaap Advertising Expense
AdvertisingExpense
0 usd
us-gaap Advertising Expense
AdvertisingExpense
374 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
255144 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16525144 shares
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
408616 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
112250 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
328116 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
440366 usd
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y6M
CY2023Q2 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
34346 usd
CY2022Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
34346 usd
CY2023Q2 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
22549 usd
CY2023Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
25903 usd
CY2023Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
48452 usd
CY2023Q2 BLPG Operating Right Of Use Assets Lease
OperatingRightOfUseAssetsLease
654966 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
654966 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
91175 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
592827 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
648002 usd
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.12 pure
CY2022 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
121095 usd
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P48Y6M
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.12 pure
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
66082 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
36105 usd
BLPG Finance Lease Expense
FinanceLeaseExpense
102187 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
68796 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
107631 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
218833 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
224230 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
193112 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
88179 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
39197 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
871182 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
223160 usd
CY2022 BLPG Finance Lease Expense
FinanceLeaseExpense
127768 usd
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
125266 usd
CY2022Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
137500 usd
CY2022Q1 us-gaap Debt Instrument Periodic Payment Principal
DebtInstrumentPeriodicPaymentPrincipal
12500 usd
CY2022Q3 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
137500 usd
CY2022Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.075 pure
CY2022Q3 BLPG Accrued Interest Debt Forgive
AccruedInterestDebtForgive
250000 usd
CY2022Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.075 pure
CY2022Q3 BLPG Default Rate Percentage
DefaultRatePercentage
0.12 pure
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
712784 usd
CY2022 BLPG Settlement Of Derivatives Upon Conversion
SettlementOfDerivativesUponConversion
-442389 usd
CY2022 us-gaap Derivative Fair Value Hedge Included In Effectiveness Gain Loss
DerivativeFairValueHedgeIncludedInEffectivenessGainLoss
180724 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
451119 usd
BLPG Settlement Of Derivatives Upon Conversion
SettlementOfDerivativesUponConversion
-47094 usd
us-gaap Derivative Fair Value Hedge Included In Effectiveness Gain Loss
DerivativeFairValueHedgeIncludedInEffectivenessGainLoss
48719 usd
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
452744 usd
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1400000000 shares
CY2021Q3 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
On July 6, 2021, the Company effected a reverse stock split and a pro-rata decrease in its authorized common stock on a basis of 1-for-100, the authorized capital of the Company concurrently decreased to 14,000,000 shares of common stock.
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
14000000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3022000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
350000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.21
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
40000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.21
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3332000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.21
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1716000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.21
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
0.21
CY2023Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
3332000 shares
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P4Y
CY2023Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
0.21
CY2023Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
1716000 shares
CY2023Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
0.21
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
39306 usd
us-gaap Share Based Compensation
ShareBasedCompensation
74316 usd

Files In Submission

Name View Source Status
blpg-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
blpg-20230630_def.xml Edgar Link unprocessable
blpg-20230630_cal.xml Edgar Link unprocessable
0001493152-23-028115-index-headers.html Edgar Link pending
0001493152-23-028115-index.html Edgar Link pending
0001493152-23-028115.txt Edgar Link pending
0001493152-23-028115-xbrl.zip Edgar Link pending
blpg-20230630.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
blpg-20230630_lab.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending